This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crossman, D. C. Articles by Maseri, A. Search for Related Content PubMed PubMed Citation Articles by Crossman, D. C. Articles by Maseri, A.

Circulation, Vol 84, 2001-2010, Copyright © 1991 by American Heart Association

ARTICLES

Responses of atherosclerotic human coronary arteries in vivo to the endothelium-dependent vasodilator substance P

DC Crossman, SW Larkin, MR Dashwood, GJ Davies, M Yacoub and A Maseri
Division of Cardiovascular Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.

BACKGROUND. The effects of the endothelium-dependent vasodilator substance P (SP) on atherosclerotic human coronary arteries was studied. METHODS AND RESULTS. [125I]-SP binding to luminal cells was shown to be preserved in the atherosclerotic epicardial coronary arteries of four patients. No binding to medial smooth muscle cells was demonstrated. Intracoronary infusions of SP were undertaken in patients with coronary artery disease. SP was infused for 2-minute periods starting at a dose of 2.8 pmol/min rising by doubling increments to 22.4 pmol/min. Analysis of the epicardial coronary artery diameter, using a computerized analysis system (CAAS) of the angiograms, was performed at the end of each infusion. Analysis of seven smooth vessel segments from seven coronary vessels, which were stenosed at more proximal sites, was performed. Significant dose-dependent dilatation was seen (p = 0.04), which was maximal at 5.6 pmol/min SP. No additional dilatation was produced with 2 mg intracoronary isosorbide dinitrate (ISDN). Two of these seven patients showed no response to SP, and only one of these appeared to sustain dilatation with ISDN (2 mg intracoronary). In a second group of six patients with discrete coronary stenoses, analysis at the site of the stenosed segments appeared to reveal dilatation in response to SP in only one instance. One other stenotic segment dilated with isosorbide dinitrate but failed to dilate with SP; the remaining four were fixed. The segment immediately proximal to the stenosis preserved a dose-dependent vasodilator response. CONCLUSIONS. These findings demonstrate that the endothelium-dependent vasodilator substance P can still produce epicardial vasodilatation in vivo in the presence of coronary atherosclerosis.

This article has been cited by other articles:

				C. Pristipino, J. F. Beltrame, M. L. Finocchiaro, R. Hattori, M. Fujita, R. Mongiardo, D. Cianflone, T. Sanna, S. Sasayama, and A. Maseri Major Racial Differences in Coronary Constrictor Response Between Japanese and Caucasians With Recent Myocardial Infarction Circulation, March 14, 2000; 101(10): 1102 - 1108. [Abstract] [Full Text] [PDF]

				D Tousoulis, C Tentolouris, T Crake, C Stefanadis, P Toutouzas, and G Davies Evidence of partially preserved endothelial dilator function in diseased coronary arteries Heart, October 1, 1999; 82(4): 471 - 476. [Abstract] [Full Text] [PDF]

				A. L'Abbate, G. Sambuceti, S. Haunso, and J. Schneider-Eicke Methods for evaluating coronary microvasculature in humans Eur. Heart J., September 2, 1999; 20(18): 1300 - 1313. [PDF]

				D Tousoulis, C Tentolouris, T Crake, G Katsimaglis, C Stefanadis, P Toutouzas, and G J Davies Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P Heart, May 1, 1999; 81(5): 505 - 511. [Abstract] [Full Text]

				C. Metais, J. Li, J. Li, M. Simons, and F. W. Sellke Effects of coronary artery disease on expression and microvascular response to VEGF Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1411 - H1418. [Abstract] [Full Text] [PDF]

				A. A. Quyyumi, D. Mulcahy, N. P. Andrews, S. Husain, J. A. Panza, and R. O. Cannon III Coronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia: Comparison of Acetylcholine and Substance P Circulation, January 7, 1997; 95(1): 104 - 110. [Abstract] [Full Text]

				T. Kuga, K. Egashira, M. Mohri, H. Tsutsui, Y. Harasawa, Y. Urabe, S. Ando, H. Shimokawa, and A. Takeshita Bradykinin-Induced Vasodilation Is Impaired at the Atherosclerotic Site but Is Preserved at the Spastic Site of Human Coronary Arteries In Vivo Circulation, July 15, 1995; 92(2): 183 - 189. [Abstract] [Full Text]